Results 1 to 10 of about 76,654 (299)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease [PDF]

Mediators of Inflammation, 2004
Background: Chemokine-driven migration of inflammatory cells has been implicated in the pathogenesis of atherosclerotic conditions including peripheral arterial disease (PAD).
Jana Petrkova, Jaroslava Szotkowska, Zuzana Hermanova, Jan Lukl, Martin Petrek   +4 more
doaj   +4 more sources

In vivo properties of monocyte chemoattractant protein-1 [PDF]

Journal of Leukocyte Biology, 1997
Abstract Monocyte chemoattractant protein-1 (MCP-1) attracts monocytes, memory T lymphocytes, and natural killer (NK) cells in vitro. Its expression has been documented in disorders characterized by mononuclear cell infiltrates, suggesting that it may contribute to the inflammatory component of such diseases as atherosclerosis, multiple ...
L, Gu, B, Rutledge, J, Fiorillo, C, Ernst, I, Grewal, R, Flavell, R, Gladue, B, Rollins   +7 more
openaire   +3 more sources

Bioluminescence imaging of mouse monocyte chemoattractant protein-1 expression in inflammatory processes [PDF]

Acta Biochimica et Biophysica Sinica, 2022
Monocyte chemoattractant protein-1 (MCP-1) plays a crucial role in various inflammatory diseases. To reveal the impact of MCP-1 during diseases and to develop anti-inflammatory agents, we establish a transgenic mouse line.
Shao Fangyang, Ci Lei, Shi Jiahao, Fang Fei, Yan Bowen, Liu Xijun, Yao Xiangyu, Zhang Mengjie, Yang Hua, Wang Zhugang, Fei Jian   +10 more
doaj   +2 more sources

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity [PDF]

Cancer Medicine, 2023
Background Oncological patients can benefit substantially from treatment with immune checkpoint inhibitors (ICI). However, there is a growing awareness of immune‐related adverse events (irAE). Especially ICI‐mediated neurological adverse events (nAE(+)),
Nora Möhn, Susann Mahjoub, Laura Duzzi, Emily Narten, Lea Grote‐Levi, Gudrun Körner, Tabea Seeliger, Gernot Beutel, Benjamin‐Alexander Bollmann, Thomas Wirth, André Huss, Hayrettin Tumani, Imke Grimmelmann, Ralf Gutzmer, Philipp Ivanyi, Thomas Skripuletz, ICOG‐CCCH (Immune Cooperative Oncology Group; Comprehensive Cancer Center Hannover)   +16 more
doaj   +2 more sources

Induction of Heme Oxygenase-1 Inhibits Monocyte Chemoattractant Protein-1 mRNA Expression in U937 Cells

Journal of Pharmacological Sciences, 2006
.: Heme oxygenase-1 (HO-1) is a stress-inducible isoform of HO with potential cytoprotective effects. Monocyte activation/migration mediated by monocyte chemoattractant protein-1 (MCP-1) is one of the earliest and important events in the pathogenesis of ...
Tomoki Shokawa, Masao Yoshizumi, Hideya Yamamoto, Shinji Omura, Mamoru Toyofuku, Yoshito Shimizu, Michinori Imazu, Nobuoki Kohno   +7 more
doaj   +2 more sources

Prognostic value of monocyte chemoattractant protein-1 in sepsis: a systematic review and meta-analysis [PDF]

BMC Immunology
Background Monocyte chemoattractant protein-1 (MCP-1) has been utilized as a prognostic indicator for sepsis patients; however, the findings have been inconsistent. This meta-analysis seeks to elucidate the prognostic significance of MCP-1 in individuals
Zhonghui Huang, Nannan Li, Wei Wang, Qing Wang, Wen Ye   +4 more
doaj   +2 more sources

Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells

FEBS Letters, 1999
The chemokine monocyte chemoattractant protein-1 is a potent chemoattractant for monocytes. Monocyte chemoattractant protein-1 is produced by vascular endothelial cells during inflammatory diseases such as atherosclerosis.
Koji Murao, Hitomi Imachi, Yoshitaka Sayo   +2 more
exaly   +2 more sources

Role of Monocyte Chemoattractant Protein-1 and its Receptor,CCR-2, in the Pathogenesis of Bleomycin-Induced Scleroderma

Journal of Investigative Dermatology, 2003
Systemic sclerosis is a connective tissue disease characterized by excessive deposition of extracellular matrix in the skin as well as various internal organs.
Toshiyuki Yamamoto
exaly   +2 more sources

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders

International Journal of Nanomedicine, 2014
Cai Yong,2,* Zhengxin Wang,1,* Xing Zhang,3 Xiaomin Shi,1 Zhijia Ni,1 Hong Fu,1 Guoshan Ding,1 Zhiren Fu,1 Hao Yin1,3 1Department of Surgery, Organ Transplant Center, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, People' ...
Yong C, Wang ZX, Zhang X, Shi XM, Ni ZJ, Fu H, Ding GS, Fu ZR, Yin H   +8 more
doaj   +1 more source

Chitinase-3-like protein 1, matrix metalloproteinase-9, and monocyte chemoattractant protein-1 as potential biomarkers and treatment targets of adenomyosis [PDF]

Obstetrics & Gynecology Science
Objective This study aimed to investigate the levels of chitinase-3-like protein-1 (CHI3L1), matrix metalloproteinase-9 (MMP-9), and monocyte chemoattractant protein-1 (MCP-1) in adenomyosis, as compared to normal myometrial tissue.
Alvin Setiawan, Hanom Husni Syam, Wiryawan Permadi, Ruswana Anwar, Tita Husnitawati Madjid, Dian Tjahyadi, Putu Doster Mahayasa   +6 more
doaj   +2 more sources